Management of Pediatric Asthma: Focus on the Expert Panel Report 3

References 

1. American Lung Association. (2005, May). Epidemiology & Statistics Unit, Research and Program Services. Trends in asthma morbidity and mortality. Washington, DC: American Lung Association. Retrieved July 2, 2009, from http://www.lungusa.org/atf/cf/{7A8D42C2-FCCA-4604-8ADE-7F5D5E762256}/ASTHMA1.PDF
2. Bloom B, Dey AN. Summary health statistics for US children: National Health Interview Survey 2004. Vital Health Statistics. 2006;1–85
3. Brown JV, Bakeman R, Celano MP, Demi AS, Kobrynski L, Wilson SR. Home-based asthma education of young low-income children and their families. Journal of Pediatric Psychology. 2002;27:677–688
   • MEDLINE
   • CrossRef
4. Butz A, Pham L, Lewis L, Lewis C, Hill K, Walker J, et al. Rural children with asthma: Impact of a parent and child asthma education program. Journal of Asthma. 2005;42:813–821
5. Cloutier MM, Hall CB, Wakefield DB, Bailit H. Use of asthma guidelines by primary care providers to reduce hospitalizations and emergency department visits in poor minority urban children. Journal of Pediatrics. 2005;146:591–597
6. de Benedictis D, Bush A. The challenge of asthma in adolescence. Pediatric Pulmonology. 2007;42:683–692
   • CrossRef
7. Dey AN, Schiller JS, Tai DA National Center for Health Statistics. Summary Health Statistics for U.S. Children: National Health Interview Survey 2002. 2004;10:1–87
8. Fabbri LM, Stoloff S. Is mild asthma really mild?. International Journal of Clinical Practice. 2005;59:692–703
   • MEDLINE
   • CrossRef
9. Finkelstein JA, Lozano P, Shulruff R, Inui TS, Soumerai SB, Ng M, et al. Self-reported physician practices for children with asthma: Are the national guidelines followed?. Pediatrics. 2000;106:886–896
10. Food and Drug Administration. (2007). FDA alert: Omalizumab (marketed as Xolair) information 2/2007. Retrieved July 3, 2009, from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm162905.htm
11. Gerald LB, Sockrider MM, Grad R, Bender BG, Boss LP, Galant SP, et al. An official ATS Workshop report: Issues in screening for asthma in children. Proceedings of the American Thoracic Society. 2007;4:133–141
    • MEDLINE
    • CrossRef
12. Gold DR, Fuhlbrigge AL. Inhaled corticosteroids for young children with wheezing. New England Journal of Medicine. 2006;354:2058–2060
13. Guibert TW, Morgan WJ, Zeiger RS, Bacharier LB, Boehmer SJ, Krawiec M, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. Journal of Clinical Immunology. 2004;114:1282–1287
14. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SL, et al. Two year inhaled corticosteroid treatment on subsequent asthma in high-risk toddlers. New England Journal of Medicine. 2006;354:1985–1997
15. Hall MJ, Owings MF. 2000 National Hospital Discharge Survey. Advance data from vital and health statistics (No. 329). Hyattsville, MD: National Center for Health Statistics; 2002;
16. Hesselmar B, Abert N, Aberg B, Eriksson B, Bjorksten B. Does early exposure to cat or dog protect against later allergy development?. Clinical and Experimental Allergy. 1999;29:611–617
17. Leone FT, Fish JE, Szefler SJ, West SL. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: Collaboration of the American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and the American College of Allergy, Asthma and Immunology. Chest. 2003;124:2329–2340
    • MEDLINE
    • CrossRef
18. Litonjua AA, Carey VJ, Burge HA, Weiss ST, Gold DR. Exposure to cockroach allergen in the home is associated with incident doctor-diagnosed asthma and recurrent wheezing. Journal of Allergy and Clinical Immunology. 2001;107:41–47
19. Morgan WJ, Crain EF, Gruchalla RS, O'Connor GT, Kattan M, Evans R, et al. Inner-City Asthma Study Group. Results of a home-based environmental intervention among urban children with asthma. New England Journal of Medicine. 2004;351:1068–1080
20. National Asthma Education and Prevention Program. Expert Panel Report 3. Guidelines for the diagnosis and management of asthma (NIH publication No. 08-5846). Bethesda, MD: National Heart Lung and Blood Institute; 2007;
21. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial: A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129:15–26
    • MEDLINE
    • CrossRef
22. Peters SP. Safety of inhaled corticosteroids in the treatment of persistent asthma. Journal of the National Medical Association. 2006;98:851–861
    • MEDLINE
23. Schatz M, Nakahiro R, Crawford W, Mendoza G, Mosen D, Stibold TB. Asthma quality of care markers using administrative data. Chest. 2005;128:1968–1973
    • MEDLINE
    • CrossRef
24. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma development and allergy at age 13. American Journal of Respiratory and Critical Care Medicine. 2005;171:137–141
    • MEDLINE
    • CrossRef
25. Stewart LJ. Pediatric asthma. Primary Care. 2008;35:25–40
    • Abstract
    • Full Text
    • Full-Text PDF (225 KB)
    • CrossRef
26. Story RE. Asthma and obesity in children. Current Opinion in Pediatrics. 2007;19:680–684
    • CrossRef
27. Taussig LM, Wright AL, Holbert CJ, Halonen M, Morgan WJ, Martinez FD. Tucson children's respiratory study. 1980 to present. Journal of Allergy and Clinical Immunology. 2003;111:661–675
28. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. New England Journal of Medicine. 2000;343:1054–1063
29. Walders N, Kopel SJ, Koinis-Mitchell D, McQuaid EL. Patterns of quick-relief and long-term controller medication use in pediatric asthma and Adherence rates may decline over time. Journal of Pediatrics. 2005;146:177–182